MML Investors Services’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,731
| Closed | -$162K | – | 2585 |
|
|
2024
Q1 | $162K | Sell |
2,731
-12,024
| -81% | -$713K | ﹤0.01% | 2378 |
|
|
2023
Q4 | $1.08M | Sell |
14,755
-1,600
| -10% | -$117K | 0.01% | 1307 |
|
|
2023
Q3 | $635K | Buy |
16,355
+2,200
| +16% | +$85.4K | ﹤0.01% | 1492 |
|
|
2023
Q2 | $817K | Buy |
14,155
+2,620
| +23% | +$151K | ﹤0.01% | 1335 |
|
|
2023
Q1 | $750K | Buy |
11,535
+1,600
| +16% | +$104K | 0.01% | 1212 |
|
|
2022
Q4 | $273K | Buy |
9,935
+940
| +10% | +$25.8K | ﹤0.01% | 1840 |
|
|
2022
Q3 | $263K | Buy |
8,995
+4,605
| +105% | +$135K | ﹤0.01% | 1766 |
|
|
2022
Q2 | $84K | Sell |
4,390
-1,660
| -27% | -$31.8K | ﹤0.01% | 1983 |
|
|
2022
Q1 | $491K | Buy |
6,050
+962
| +19% | +$78.1K | ﹤0.01% | 1465 |
|
|
2021
Q4 | $466K | Buy |
5,088
+600
| +13% | +$55K | ﹤0.01% | 1456 |
|
|
2021
Q3 | $561K | Buy |
4,488
+1,040
| +30% | +$130K | ﹤0.01% | 1282 |
|
|
2021
Q2 | $390K | Buy |
3,448
+1,340
| +64% | +$152K | ﹤0.01% | 1467 |
|
|
2021
Q1 | $319K | Sell |
2,108
-550
| -21% | -$83.2K | ﹤0.01% | 1483 |
|
|
2020
Q4 | $306K | Buy |
2,658
+1,508
| +131% | +$174K | ﹤0.01% | 1381 |
|
|
2020
Q3 | $89K | Buy |
+1,150
| New | +$89K | ﹤0.01% | 1543 |
|